Why the study?
Does a target systolic blood pressure of <130 mm Hg reduce left ventricular hypertrophy and atrial fibrillation in nondiabetic patients compared to a target of <140 mm Hg?
Does a target systolic blood pressure of <130 mm Hg reduce left ventricular hypertrophy and atrial fibrillation in nondiabetic patients compared to a target of <140 mm Hg?
Answers are grounded in this paper and cite their sources.
Tight blood pressure control (systolic BP <130 mm Hg) is advocated over standard control (<140 mm Hg) to better reduce left ventricular hypertrophy and atrial fibrillation.
Dear Sir,Notwithstanding the documentation that better adherence reduces the risk of heart failure ‘there is much more that can be performed to improve health through …control of hypertension’ [1]. A demonstration of how much more can be performed was strikingly exemplified by the documentation that, in nondiabetic patients of mean age 67, the use of a target systolic blood pressure of <130 mm Hg (defined as ‘tight’ control) was significantly (P = 0.013) superior to the use of a target BP of <140 mm Hg for reducing the likelihood of subsequent left ventricular hypertrophy on 2-year follow-up. During that follow-up period, new-onset atrial fibrillation also had a significantly (P = 0.044) lower prevalence in patients assigned to tight control [2]. Accordingly, the prevailing paradigm which defines control of blood pressure as attainment of a systolic BP below 140 mm Hg needs to be revised because it generates a false sense of security. For example, in 2003 a survey of 8834 English adults aged 16 or more revealed that, amongst those with hypertension only 21.8% had ‘adequate’ blood pressure control when the latter was defined as blood pressure ≤140/90 mm Hg [3]. As a result of the implementation of a Quality and Outcomes Framework for monitoring blood pressure in registered patients aged 45 or more [4] a subsequent survey undertaken in 2006 showed that ‘control rates (<140/90 mm Hg) were higher in 2006 than in 2003 (from 22% to 28%; P < 0.001) [5]’. Although reassuring, these statistics do not necessarily translate into a benefit for those patients in whom ‘adequate’ blood pressure control does not equate with tight control, hence the requirement for a major paradigm shift in treatment goals and in performance indicators so as to ensure that control of hypertension does indeed improve health. None.
No takes yet. Share an insight, caveat, or question.
Oscar M.P. Jolobe (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: